UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor

Glia, 2016-10, Vol.64 (10), p.1788-1794

2016

Volltextzugriff (PDF)

Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals

Science (American Association for the Advancement of Science), 2009-06, Vol.324 (5933), p.1441-1444

2009

Volltextzugriff (PDF)

KCa3.1-a microglial target ready for drug repurposing?

Glia, 2016-10, Vol.64 (10), p.1733-1741

2016

Volltextzugriff (PDF)

Senicapoc: Repurposing a Drug to Target Microglia KCa3.1 in Stroke

Neurochemical research, 2017-09, Vol.42 (9), p.2639-2645

2017

Volltextzugriff (PDF)

Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain

Purinergic signalling, 2022-12, Vol.18 (4), p.499-514

2022

Volltextzugriff (PDF)

Alpha-synuclein overexpression increases cytosolic catecholamine concentration

The Journal of neuroscience, 2006-09, Vol.26 (36), p.9304-9311

2006

Volltextzugriff (PDF)

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

Frontiers in pharmacology, 2019-08, Vol.10, p.840-840

2019

Volltextzugriff (PDF)

PKC θ activity maintains normal quantal size in chromaffin cells

Journal of neurochemistry, 2008-06, Vol.105 (5), p.1635-1641

2008

Volltextzugriff (PDF)

Dopamine neurons release transmitter via a flickering fusion pore

Nature neuroscience, 2004-04, Vol.7 (4), p.341-346

2004

Volltextzugriff (PDF)

K Ca 3.1—a microglial target ready for drug repurposing?

Glia, 2016-10, Vol.64 (10), p.1733-1741

2016

Volltextzugriff (PDF)

Dopamine release at individual presynaptic terminals visualized with FFNs

Journal of visualized experiments, 2009-08 (30)

2009

Volltextzugriff (PDF)

Senicapoc: Repurposing a Drug to Target Microglia K^sub Ca^3.1 in Stroke

Neurochemical research, 2017-09, Vol.42 (9), p.2639

2017

Volltextzugriff (PDF)

Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury

European journal of pharmacology, 2017-01, Vol.795, p.1-7

2017

Volltextzugriff (PDF)

Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2217-2220

2000

Volltextzugriff (PDF)

Inhibition of the potassium channel K Ca 3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury

European journal of pharmacology, 2017-01, Vol.795, p.1-7

2017

Volltextzugriff (PDF)

K sub(Ca)3.1-a microglial target ready for drug repurposing?

Glia, 2016-10, Vol.64 (10), p.1733-1741

2016

Volltextzugriff (PDF)

KCa 3.1-a microglial target ready for drug repurposing?

Glia, 2016-10, Vol.64 (10), p.1733-1741

2016

Volltextzugriff (PDF)

Senicapoc: Repurposing a Drug to Target Microglia K Ca 3.1 in Stroke

Neurochemical research, 2017-09, Vol.42 (9), p.2639

2017

Volltextzugriff (PDF)

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2217-2220

2000

Volltextzugriff (PDF)

PKC 0 activity maintains normal quantal size in chromaffin cells

Journal of neurochemistry, 2008, Vol.105 (5), p.1635-1641

2008

Volltextzugriff (PDF)

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

The Journal of pharmacology and experimental therapeutics, 2000-05, Vol.293 (2), p.336

2000

Volltextzugriff (PDF)

Recent Developments in Targeting Neuroinflammation in Disease

Annual Reports in Medicinal Chemistry, 2012, Vol.47, p.37-53

2012

Volltextzugriff (PDF)

In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium

The Journal of pharmacology and experimental therapeutics, 2000-05, Vol.293 (2), p.329

2000

Volltextzugriff (PDF)

PKC [theta] activity maintains normal quantal size in chromaffin cells

Journal of neurochemistry, 2008-06, Vol.105 (5), p.1635-1641

2008

Volltextzugriff (PDF)

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Journal of visualized experiments, 2009-08 (30)

2009

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)
Buchkapitel
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Animals
(14)
Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Mice
(8)
Neurosciences
(8)
Microglia
(7)
Neurosciences & Neurology
(7)
Rats
(7)
Male
(6)
Humans
(5)
Synaptic Vesicles - Metabolism
(5)
Dopamine - Metabolism
(4)
Membrane Transport Proteins
(4)
Microglia - Drug Effects
(4)
Neuropeptides
(4)
Pharmacology & Pharmacy
(4)
Rats, Sprague-Dawley
(4)
Vesicular Biogenic Amine Transport Proteins
(4)
Vesicular Monoamine Transport Proteins
(4)
Biochemistry & Molecular Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor

Fluorescent False Neurotransmitters Visualize Dopamine Release from Individual Presynaptic Terminals

KCa3.1-a microglial target ready for drug repurposing?

Senicapoc: Repurposing a Drug to Target Microglia KCa3.1 in Stroke

Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain

Alpha-synuclein overexpression increases cytosolic catecholamine concentration

Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

PKC θ activity maintains normal quantal size in chromaffin cells

Dopamine neurons release transmitter via a flickering fusion pore

K Ca 3.1—a microglial target ready for drug repurposing?

Dopamine release at individual presynaptic terminals visualized with FFNs

Senicapoc: Repurposing a Drug to Target Microglia K^sub Ca^3.1 in Stroke

Inhibition of the potassium channel KCa3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury

Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

Inhibition of the potassium channel K Ca 3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury

K sub(Ca)3.1-a microglial target ready for drug repurposing?

KCa 3.1-a microglial target ready for drug repurposing?

Senicapoc: Repurposing a Drug to Target Microglia K Ca 3.1 in Stroke

Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations

PKC 0 activity maintains normal quantal size in chromaffin cells

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

Recent Developments in Targeting Neuroinflammation in Disease

In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium

PKC [theta] activity maintains normal quantal size in chromaffin cells

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Suchergebnisse filtern